Vitamin K epoxide reductase complex 1 polymorphism and warfarin dose in African Americans.

被引：0
|
作者：
Momary, KM
Nutescu, EA
Shapiro, NL
Viana, MA
Helgason, CM
Cavallari, LH
机构：
[1] Univ Illinois, Coll Pharm, Chicago, IL USA
[2] Univ Illinois, Coll Med, Chicago, IL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2005.12.116
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P32 / P32
页数：1
相关论文
共 50 条
  • [41] FORMATION OF HYDROXYVITAMIN-K BY VITAMIN-K EPOXIDE REDUCTASE OF WARFARIN-RESISTANT RATS
    FASCO, MJ
    PREUSCH, PC
    HILDEBRANDT, E
    SUTTIE, JW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1983, 258 (07) : 4372 - 4380
  • [42] LIVER EQTLS FOR WARFARIN DOSE RESPONSE GENES REVEAL SUSCEPTIBILITY TO VENOUS THROMBOEMBOLISM AMONG AFRICAN AMERICANS.
    Hernandez, W.
    Gamazon, E. R.
    Aquino-Michaels, K.
    Patel, S.
    O'Brien, T. J.
    Harralson, A. F.
    Kittles, R. A.
    Barbour, A.
    Tuck, M.
    McIntosh, S. D.
    Douglas, J. N.
    Nicolae, D.
    Cavallari, L. H.
    Perera, M. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S60 - S60
  • [43] A Polymorphism in the VKORC1 Regulator Calumenin Predicts Higher Warfarin Dose Requirements in African Americans
    Voora, D.
    Koboldt, D. C.
    King, C. R.
    Lenzini, P. A.
    Eby, C. S.
    Porche-Sorbet, R.
    Deych, E.
    Crankshaw, M.
    Milligan, P. E.
    McLeod, H. L.
    Patel, S. R.
    Cavallari, L. H.
    Ridker, P. M.
    Grice, G. R.
    Miller, R. D.
    Gage, B. F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (04) : 445 - 451
  • [44] Effects of vitamin K epoxide reductase complex 1 gene polymorphisms on warfarin control in Japanese patients with left ventricular assist devices (LVAD)
    Kazuki Nakagita
    Kyoichi Wada
    Yutaro Mukai
    Takaya Uno
    Ryoji Nishino
    Sachi Matsuda
    Hiromi Takenaka
    Nobue Terakawa
    Akira Oita
    Mitsutaka Takada
    European Journal of Clinical Pharmacology, 2018, 74 : 885 - 894
  • [45] Effects of vitamin K epoxide reductase complex 1 gene polymorphisms on warfarin control in Japanese patients with left ventricular assist devices (LVAD)
    Nakagita, Kazuki
    Wada, Kyoichi
    Mukai, Yutaro
    Uno, Takaya
    Nishino, Ryoji
    Matsuda, Sachi
    Takenaka, Hiromi
    Terakawa, Nobue
    Oita, Akira
    Takada, Mitsutaka
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (07) : 885 - 894
  • [46] The influence of (R)- and (S)-warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation
    Kamali, F
    Edwards, C
    Butler, TJ
    Wynne, HA
    THROMBOSIS AND HAEMOSTASIS, 2000, 84 (01) : 39 - 42
  • [47] R-WARFARIN AND S-WARFARIN INHIBITION OF VITAMIN-K AND VITAMIN-K-2,3-EPOXIDE REDUCTASE ACTIVITIES IN THE RAT
    FASCO, MJ
    PRINCIPE, LM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1982, 257 (09) : 4894 - 4901
  • [48] A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistance
    Bodin, L
    Horellou, MH
    Flaujac, C
    Loriot, MA
    Samama, MM
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (07) : 1533 - 1535
  • [49] Warfarin traps human vitamin K epoxide reductase in an intermediate state during electron transfer
    Guomin Shen
    Weidong Cui
    Hao Zhang
    Fengbo Zhou
    Wei Huang
    Qian Liu
    Yihu Yang
    Shuang Li
    Gregory R Bowman
    J Evan Sadler
    Michael L Gross
    Weikai Li
    Nature Structural & Molecular Biology, 2017, 24 : 69 - 76
  • [50] Warfarin traps human vitamin K epoxide reductase in an intermediate state during electron transfer
    Shen, Guomin
    Cui, Weidong
    Zhang, Hao
    Zhou, Fengbo
    Huang, Wei
    Liu, Qian
    Yang, Yihu
    Li, Shuang
    Bowman, Gregory R.
    Sadler, J. Evan
    Gross, Michael L.
    Li, Weikai
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2017, 24 (01) : 69 - 76
12345